Mads Melbye

Mads Melbye is a Professor at the Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), conducting extensive epidemiological research using Scandinavian population-based cohorts. His work spans cardiovascular disease, oncology, endocrinology, and genetics, with recent publications in high-impact journals including The Lancet, JAMA, and The BMJ.

Research Interests: His primary focus areas include Epidemiology, Cardiovascular Disease, Oncology, Endocrinology, Neurology, Psychiatry, Genetics, and Obstetrics. He specializes in large-scale cohort studies and registry-based research, particularly utilizing Scandinavian health data to investigate drug safety (e.g., statins, GLP-1 receptor agonists), genetic risk factors, and environmental influences on conditions like asthma and depression.

Publication Trends: Analysis of his 2022-2025 work reveals dominant themes in cardiovascular outcomes related to medications (SGLT2 inhibitors, GLP-1 agonists), cancer treatment safety (aromatase inhibitors in breast cancer), and psychiatric conditions (postpartum depression). His Scandinavian cohort-based studies consistently address real-world clinical questions with significant public health implications.

Collaborations & Contact: Professor Melbye maintains extensive collaborations across Scandinavian institutions, particularly in Denmark and Sweden. His primary contact is mads.melbye@ntnu.no.